Abiraterone Reduced Morbidity in MCRPC Patients
Treatment with both drugs also delayed times to opiate use and chemotherapy, was associated with improved quality of life measures, and remained safe and well tolerated, said Dr. Dana E. Rathkopf, the...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news
More News: Cancer & Oncology | Chemotherapy